Literature DB >> 22232054

Longitudinal assessment of oxaliplatin-induced neuropathy.

Susanna B Park, Martin Koltzenburg, Cindy S -Y Lin, Matthew C Kiernan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22232054     DOI： 10.1212/01.wnl.0000410913.88642.bf

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  3 in total

1.  Impact of Dose, Sex, and Strain on Oxaliplatin-Induced Peripheral Neuropathy in Mice.

Authors:  Urszula O Warncke; Wisam Toma; Julie A Meade; Abigail J Park; Danielle C Thompson; Martial Caillaud; John W Bigbee; Camron D Bryant; M Imad Damaj
Journal:  Front Pain Res (Lausanne)       Date:  2021-07-22

2.  Neuropathy experienced by colorectal cancer patients receiving oxaliplatin: A qualitative study to validate the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scale.

Authors:  Karen Kaiser; Madison Lyleroehr; Sara Shaunfield; Leilani Lacson; Maria Corona; Sheetal Kircher; Malin Nittve; David Cella
Journal:  World J Gastrointest Oncol       Date:  2020-02-15

3.  Peripheral nerve axonal excitability studies: expanding the neurophysiologist's armamentarium.

Authors:  William Huynh; Matthew C Kiernan
Journal:  Cerebellum Ataxias       Date:  2015-03-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.